A phase 2 study of fosaprepitant combined with high-dose dexamethasone for Japanese cancer patients receiving highly emetogenic chemotherapy-Reference-Cited by-同舟云学术

A phase 2 study of fosaprepitant combined with high-dose dexamethasone for Japanese cancer patients receiving highly emetogenic chemotherapy

Published:2018-06 Issue:25 Volume:97 Page:e11042
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Kumagai Hozumi,Kusaba Hitoshi,Yamanaka Takeharu,Nio Kenta,Inadomi Kyoko,Takayoshi Kotoe,Ito Mamoru,Tamura Shingo,Makiyama Akitaka,Makiyama Chinatsu,Hirano Gen,Shibata Yoshihiro,Shirakawa Tsuyoshi,Mitsugi Kenji,Ariyama Hiroshi,Esaki Taito,Akashi Koichi,Baba Eishi

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference13 articles.

1. Antiemetics: American Society of Clinical Oncology Focused Guideline Update;Hesketh;J Clin Oncol,2015

2. Single-dose fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with cisplatin therapy: randomized, double-blind study protocol--EASE;Grunberg;J Clin Oncol,2011

3. Efficacy and safety of single-dose fosaprepitant in the prevention of chemotherapy-induced nausea and vomiting in patients receiving high-dose cisplatin: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial;Saito;Ann Oncol,2013

4. Effects of the neurokinin1 receptor antagonist aprepitant on the pharmacokinetics of dexamethasone and methylprednisolone;McCrea;Clin Pharmacol Ther,2003

5. Randomized, double-blind, phase III trial of palonosetron versus granisetron in the triplet regimen for preventing chemotherapy-induced nausea and vomiting after highly emetogenic chemotherapy: TRIPLE study;Suzuki;Ann Oncol,2016

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Strategy of targeting the tumor microenvironment via inhibition of fibroblast/fibrosis remodeling new era to cancer chemo-immunotherapy resistance;European Journal of Pharmacology;2023-10

2. High-Dose Dexamethasone Manipulates the Tumor Microenvironment and Internal Metabolic Pathways in Anti-Tumor Progression;International Journal of Molecular Sciences;2020-03-07